نمایش پرونده ساده آیتم

dc.contributor.authorNejati-Azar, A
dc.contributor.authorAlivand, MR
dc.date.accessioned2018-08-26T09:01:46Z
dc.date.available2018-08-26T09:01:46Z
dc.date.issued2018
dc.identifier.urihttp://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/55034
dc.description.abstractAim: The purpose of our study was to analyze association of miRNAs 146aG/C(2910164) and 196a2C/T(11614913) polymorphism with breast cancer (BC) risk for women of Azeri ethnicity in Iran. Materials & methods: In the current case (n = 200)-control (n = 200) study, miRNAs 146aG/C(2910164) and 196a2C/T(11614913) were investigated for allelic and genotypic levels via the PCR-restriction fragment length polymorphism technique. Results: The statistical analysis showed a significant relation between CC genotype of rs11614913(196a2) (codominant, odds ratio (OR) = 0.58, p = 0.02236; recessive, OR = 2.92, p = 0.01695; overdominant, OR = 0.44, p = 0.0113) and BC susceptibility. The subgroup analysis of mentioned polymorphism declared the significant correlation (p ? 0.05) of the positive abortion, regular menstruation, positive human epidermal receptor-2 and positive estrogen receptor with BC susceptibility in CC genotype. Conclusion: The existence of a C-allele at miRNA 196a2(11614913) elevates women's BC susceptibility in Azeri ethnicity in Iran. © 2018 Future Medicine Ltd.
dc.language.isoEnglish
dc.relation.ispartofPersonalized Medicine
dc.titleMiRNA 196a2(rs11614913) & 146a(rs2910164) polymorphisms & breast cancer risk for women in an Iranian population
dc.typeArticle
dc.citation.volume15
dc.citation.issue4
dc.citation.spage279
dc.citation.epage289
dc.citation.indexScopus
dc.identifier.DOIhttps://doi.org/10.2217/pme-2017-0088


فایلهای درون آیتم

فایلهاسایزفرمتنمایش

هیچ فایل مرتبطی وجود ندارد

این آیتم در مجموعه های زیر مشاهده می شود

نمایش پرونده ساده آیتم